EUVIMEDEUVIMED entdecken
Crossref

Microbiome in pancreatic cancer – What is new in 2024?

E. Hohmann, C. Ammer-Herrmenau, C. Schulz, S. Sirtl

Microbiota in Health and Disease · 2024-10 · 6

DOI: 10.26355/mhd_202410_1100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiota in Health and Disease, 2024-10. Verfasst von E. Hohmann und 3 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite great efforts to improve understanding and treatment of pancreatic cancer, mainly pancreatic ductal adenocarcinoma (PDAC), the outcome of this malignant disease today is still very poor. With the introduction of modern sequencing methods and improvements in computational possibilities, microbiome research is an improving and promising field with a link to many possible diseases. In this article, the results of how the microbiome and PDAC influence each other are reviewed, and future directions are discussed.

Schlagwörter

pancreatic cancerpancreatic ductal adenocarcinomapdacmicrobiome.

Zitieren

APA

Hohmann, E., Ammer-Herrmenau, C., Schulz, C., & Sirtl, S. (2024). Microbiome in pancreatic cancer – What is new in 2024?. Microbiota in Health and Disease, 6. https://doi.org/10.26355/mhd_202410_1100

Vancouver

Hohmann E, Ammer-Herrmenau C, Schulz C, Sirtl S. Microbiome in pancreatic cancer – What is new in 2024?. Microbiota in Health and Disease. 2024;6. doi:10.26355/mhd_202410_1100

BibTeX
@article{Hohmann2024,
  author = {Hohmann, E. and Ammer-Herrmenau, C. and Schulz, C. and Sirtl, S.},
  title = {Microbiome in pancreatic cancer – What is new in 2024?},
  journal = {Microbiota in Health and Disease},
  year = {2024},
  volume = {6},
  doi = {10.26355/mhd_202410_1100}
}
Kostenlos starten →